DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

5.30 -0.13 (-2.39%)

REAL-TIME: Last trade at

Extended Hours: $5.30 $0.00 (-0.02%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

PGNX $5.30 -2.39%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.36
Previous Close $5.43
Daily Range $5.23 - $5.47
52-Week Range $3.10 - $7.45
Market Cap $368.6M
P/E Ratio -8.90
Dividend (Yield) $0.00 (0.0%)
Volume 921,673
Average Daily Volume 1,038,219
Current FY EPS -$0.02

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

2nd Half Of 2014 Biotechnology Catalysts--Part 4

Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog

US Stock Futures Signal Higher Start On Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q2 2014 Results - Earnings Call Transcript

Progenics Pharmaceuticals (PGNX) Q2 2014 Results - Earnings Call Webcast

Earnings Scheduled For August 8, 2014

Will Progenics (PGNX) Disappoint this Earnings Season? - Analyst Blog

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

An Inefficient Stock Market Will Catch Up To Progenics

See More PGNX News...

PGNX's Top Competitors

PGNX $5.30 (-2.39%)
Current stock: PGNX
AMGN $138.69 (0.62%)
Current stock: AMGN
GILD $107.51 (0.09%)
Current stock: GILD
BIIB $341.24 (-0.62%)
Current stock: BIIB